Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dimethindene
Strength: 1 mg
Dosage form: emulsión cutánea
Route: uso cutáneo
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 6 Jul 2020
Registration: 37189-7-6-2010
Marketing authorisation holder: Glaxosmithkline Consumer Healthcare Hellas S.A.
Procedure: National, MRP or DCP
Supply: Sin Receta

FENISTIL 1 mg/g GELDimethindene · 100 mg · gelSpain

Fenistil 1 MG/ML Emulsión CutáneaDimethindene · 1 mg · emulsión cutáneaSpain

Relipic 1MG/G GelDimethindene · 1 mg/g · gelSpain

FENISTIL 1 mg/g GELDimethindene · 1 mg · gelSpain

Fenistil EmulsionDimethindene · 1 mg · emulsión cutáneaSpain

Fenistil 1 MG/G GelDimethindene · 1 mg · gelSpain